Health Secretary Wes Streeting has declared that securing a timely cancer diagnosis "shouldn't be a question of luck," as he unveiled a major funding boost aimed at bringing patient checks closer to home. The government is investing £237 million into new and enhanced community diagnostic centres (CDCs) throughout England, marking what Streeting described as "part of the biggest expansion in NHS diagnostics in a generation."
Personal Experience Drives Policy Initiative
Speaking from personal experience, Mr Streeting revealed, "I was one of the lucky ones – my kidney cancer was caught early, and today I'm living cancer-free. But it shouldn't be a question of luck. The NHS should be there for all of us when we need it, catching illness earlier so we can treat it faster."
Substantial Investment in Diagnostic Infrastructure
The substantial investment will facilitate the establishment of four brand new CDCs in Gorton, Luton, Boston, and Bideford, all scheduled to open during the 2026/27 period. Additionally, seventeen existing centres will undergo expansion, while fifteen others will receive enhancements specifically designed to boost diagnostic capacity, according to the Department of Health and Social Care.
Mr Streeting elaborated on the strategic approach, stating, "These new CDCs are part of the biggest expansion in NHS diagnostics in a generation – continuing the progress we're making and helping save lives. We're not just investing in more, but delivering differently. The NHS should fit around people's lives, not require patients to fit their lives around the NHS."
Convenient Access for Patients
The Health Secretary emphasized the practical benefits for patients, explaining that community diagnostic centres will enable individuals to obtain tests, checks, and scans during routine activities. "Patients can get these services while they're doing their shopping on the weekend or on the way to pick up the kids from school – without travelling across town to a hospital," he noted.
Current NHS Performance Context
This announcement coincides with the NHS preparing to publish its latest performance figures. Recent data indicates that the waiting list for routine hospital treatment remains at its lowest level since early 2023, with an estimated 7.25 million treatments awaiting completion at the end of January, affecting 6.13 million patients.
Notably, 135,657 people had been waiting more than a year to begin routine hospital treatment at the end of January – representing the lowest figure for such extended waits since August 2020. However, cancer diagnosis statistics reveal a concerning trend, with only 72.8% of patients urgently referred for suspected cancer receiving a diagnosis or having cancer ruled out within 28 days in January, down from 77.4% in December and below the current target of 75%.
Clinical Support for Expansion
Professor Stella Vig, national clinical director for elective care at NHS England, expressed strong support for the initiative, stating, "We're making it easier to access care, and our network of community diagnostic centres deliver important diagnostic tests nearer to people's homes, with new, expanded or enhanced centres available to patients across England. This expansion means even more patients can have vital checks like MRIs, CT scans and ultrasounds in a convenient location at a time that suits them, supporting the NHS's drive to bring down waiting times even further."
The investment represents a significant step toward transforming how diagnostic services are delivered within the National Health Service, with the ultimate goal of ensuring that timely cancer detection becomes a standard expectation rather than a matter of fortunate circumstance for patients across the country.
